Name | 4-piperazin-1-ylbenzoic acid |
---|---|
Synonyms |
4-(Piperazin-1-yl)benzoic acid
4-(1-Piperazinyl)benzoic acid 4-Piperazino-benzoesaeure Benzoic acid, 4-(1-piperazinyl)- MFCD03444417 4-piperazino-benzoic acid |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 424.7±30.0 °C at 760 mmHg |
Melting Point | 295ºC |
Molecular Formula | C11H14N2O2 |
Molecular Weight | 206.241 |
Flash Point | 210.6±24.6 °C |
Exact Mass | 206.105530 |
PSA | 52.57000 |
LogP | 0.79 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.581 |
Storage condition | 2-8°C |
Hazard Codes | Xi: Irritant; |
---|---|
Risk Phrases | R36/37/38 |
Safety Phrases | 26-36/37/39 |
HS Code | 2933599090 |
~59% 85474-75-5 |
Literature: THERAVANCE, INC. Patent: US2012/114600 A1, 2012 ; |
~% 85474-75-5 |
Literature: US2012/114600 A1, ; |
~% 85474-75-5 |
Literature: US2012/114600 A1, ; |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |